Now Available on CCO HIV

 

DOWNLOAD AUDIO AND VIDEO SEGMENTS

 

CCO HIV: Stay Tuned Now Available
Evolving Concepts in Antiretroviral Therapy—Volume 1, Edition 1

 

Watch and listen to CCO's expert faculty discuss evolving concepts in antiretroviral therapy. Then download audio, video, and slides for additional reference and use in your own talks.  Click here to start.

Treatment Update

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy


Now Available!

CME-certified Virtual Presentaion:

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy
Paul E. Sax, MD, discusses the latest data regarding when to start antiretroviral therapy.

CME-certified Slideset:

 

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy
Paul E. Sax, MD, reviews the optimal timing of antiretroviral therapy in response to revised recommendations issued by the Department of Health and Human Services.

CCO Conference Coverage

CCO Independent Conference Coverage of the 2008 Conference on Retroviruses and Opportunistic Infections

Review audio Expert Highlights and Capsule Summaries of the most clinically relevant data from this important annual meeting!


CME-Certified Expert Analyses:


First-Line Therapy and Switch Strategies

Joel E. Gallant, MD, MPH; Charles B. Hicks, MD; Kathleen E. Squires, MD

Management of Treatment-Experienced Patients

Joseph J. Eron, Jr., MD; W. David Hardy, MD; Kimberly Y. Smith, MD, MPH

Antiretroviral Drug Resistance

Eric S. Daar, MD; Daniel R. Kuritzkes, MD; Andrew R. Zolopa, MD

Metabolic Complications and Adverse Events

Andrew Carr, MD; Judith S. Currier, MD, MSc; William G. Powderly, MD

Hepatitis and Opportunistic Coinfections

Richard E. Chaisson, MD; Bruce Polsky, MD; Jürgen K. Rockstroh, MD


CME-Certified Expert Recaps:


And downloadable PowerPoint slides for review or to use in your own talks!

Treatment Update

Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV


CME-Certified Modules:

Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

Sally Hodder, MD; Paul E. Sax, MD; and Pablo Tebas, MD, provide practical answers to frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.

Coming Soon!

Faculty Responses to Readers’ Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

 

CCO Slideset:

Answering the Questions: Practical Management Strategies for Cardiovascular Risk in HIV

Pablo Tebas, MD reviews key data on frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.

Treatment Update

Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents

CME-Certified Virtual Presentation and Downloadable PowerPoint Slideset:

Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents
Joseph J. Eron, Jr., MD, discusses clinical data and strategies important for optimal use of next-generation NNRTIs in the management of HIV-infected patients.

CCO Slideset: Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents
PowerPoint slideset available for review and use in your own educational presentations.

CME-Certified Case Vignettes:

Clinical Management of a Patient Who Develops Additional Resistance Mutations When Maintained on a Failing Antiretroviral Regimen
Joseph J. Eron, Jr., MD, discusses the management of an HIV-infected male who experiences treatment failure and subsequently develops multiple resistance mutations.

Selecting an Antiretroviral Regimen in a Treatment-Experienced Patient Who has Never Achieved Undetectable Viral Load
Pablo Tebas, MD, reviews considerations influencing management strategies in a patient with virologic failure and multidrug-resistant HIV.

Using Recently Approved Antiretrovirals in the Management of a Highly Treatment-Experienced HIV-Infected Woman
W. David Hardy, MD, discusses considerations when deciding which new antiretroviral agents to use in the clinical management of a highly treatment-experienced HIV-infected woman.

 

Management Series

Psychiatric Disorders in HIV-Infected Patients


CME-certified Modules:

Diagnosis and Treatment of Psychiatric Disorders in HIV-Infected Patients
Stephen J. Ferrando, MD, outlines current understanding of psychiatric comorbidities in HIV-infected patients and treatment for each disorder.

Impact of Psychiatric Disorders on HIV Management
Ian Everall, FRCPath, FRCPsych, PhD, discusses the clinical management of HIV-infected individuals with mental illnesses such as major depressive disorder, anxiety disorders, psychotic disorders, and substance abuse.


CME-certified Interactive Case Challenge:

Initiating Therapy in a Patient With Substance Abuse Disorder
Andrew Angelino, MD, guides the participant through the decisions that might be faced when starting antiretroviral medications in a patient with a chaotic lifestyle and substance addiction.

Managing Therapy in a Patient With Increasing Anxiety
Stephen J. Ferrando, MD, describes management of a young HIV-infected woman with posttraumatic stress disorder.

 

Managing Adherence in a Patient With Multiple Medical Disorders and an Affective Disorder
Mary Alice O’Dowd, MD, guides the participant through a case involving a middle-aged patient with multiple medical disorders who must manage her antiretroviral medications, her other essential medications, and treatment for an affective disorder.

Journal Options

HIV Journal Options - Volume 4, Issue 1

HIV Journal Options - Volume 4, Issue 2


Topics include:

  • New and approved agents in HIV treatment–experienced patients
  • Association between CD4+ cell count at antiretroviral initiation and immunologic outcome
  • Cardiovascular risk in HIV-infected patients
  • Impact of previous successful hepatitis C therapy on the risk of hepatotoxicity in HIV-infected patients receiving antiretroviral therapy
  • Relationship between patient sex and response to efavirenz therapy

Treatment Update

Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection


CME-certified modules:

CME-certified Interactive Case Challenges:

CME-certified slideset module:

Downloadable PowerPoint Slideset:

Treatment Update

Simple From the Start

Now Available!


2 CME-certified modules by Edwin DeJesus, MD, FACP:

Recent Advances in Simplifying Antiretroviral Therapy


Clinical Significance of Simplicity and Adherence in Antiretroviral Therapy

Edwin DeJesus, MD, FACP, discusses key advances toward simpler antiretroviral treatments and their clinical use in antiretroviral-naive patients.


CME-certified Interactive Case Challenges:

Selection of Initial Therapy for a 48-Year-Old HIV/TB-Coinfected Woman With CVD Risk Factors

Anton L. Pozniak, MD, FRCP, discusses drug interaction and adherence issues in designing a therapy for a 48-year-old woman coinfected with HIV and tuberculosis.

Management of a 38-Year-Old Male on Methadone Maintenance Therapy Who Presents With PCP

William G. Powderly, MD, discusses the selection of initial therapy for a 38-year-old recovering injection drug user male with HIV/hepatitis C virus coinfection who presents with Pneumocystis jirovecii pneumonia (PCP).

Management of a 38-Year-Old Otherwise Healthy Married Man Recently Diagnosed With HIV Infection

Edwin DeJesus, MD, FACP, discusses key concerns about the initiation of antiretroviral therapy for a 38-year-old busy professional man recently diagnosed with HIV.

Treatment Update

The Clinical Impact of Next-Generation NNRTIs: Recent Research and Practical Treatment Strategies

A comprehensive review of data from clinical trials investigating first- and next-generation NNRTIs as well as a discussion regarding the clinical need for and potential impact of next-generation NNRTIs.

Virtual Presentation
The Clinical Need for Next-Generation NNRTIs

Virtual Presentation
The Potential Clinical Impact of Next-Generation NNRTIs

A CME-certified Module:
The Next Generation of NNRTIs

Management Series

When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy


CME-certified modules:

Timing of Antiretroviral Initiation in Treatment-Naive Patients
Keith Henry, MD, discusses how the December 2007 update of the DHHS guidelines may affect clinical practice regarding when to initiate antiretroviral therapy in treatment-naive patients.

Clinical Trials of Antiretroviral Therapy in Treatment-Naive Patients
Marshall J. Glesby, MD, PhD, discusses the results from the latest clinical trials on antiretroviral therapy options for the management of treatment-naive patients.

Antiretroviral Selection in Treatment-Naive Patients
Paul E. Sax, MD, reviews data concerning the use of current antiretroviral drugs and novel therapies to outline optimal management strategies for treatment-naive patients.


CME-certified Interactive Case Challenges:

When to Initiate Therapy in a Patient Recently Diagnosed With HIV
Along with Keith Henry, MD, determine when to start antiretroviral therapy in a recently HIV-infected, treatment-naive patient based on the updated DHHS treatment guidelines released in December 2007.

Management of an HIV-Infected Treatment-Naive Diabetic Female With Dyslipidemia   
Along with Marshall J. Glesby, MD, PhD, choose the optimal management strategies for a treatment-naive HIV-infected diabetic female with dyslipidemia.

Treatment Considerations in an HIV-Infected Patient With Ongoing Methamphetamine Use
Along with Paul E. Sax, MD, choose the optimal management strategies for a HIV-infected, treatment-naive patient with ongoing substance abuse based on the updated DHHS treatment guidelines released in December 2007.


Interactive Tool Also Available:
Choosing First-Line Antiretroviral Therapy

Case Challenges

Annual Update

More CCO Independent Conference Coverage

More Treatment Updates

Browse HIV

CCO HIV Stay Tuned

 

FEATURED VIDEO SEGMENT
New Drugs in Clinical Practice: Update From Boston

 

Sharon L. Walmsley, MSc, MD, FRCPC discusses data from the retroviruses meeting in Boston. Click here to Start

New Data

Increased Risk for Disease Progression With Longer Delay Until Regimen Modification in Patients Failing First-Line NNRTI-Based Treatment

 

NNRTI-based regimens were found to be less forgiving than PI-based regimens regarding risk of immunologic failure and mortality in patients experiencing virologic failure.

 

Click here for related Capsule Summaries.

Slidesets

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy

Paul E. Sax, MD, reviews the optimal timing of antiretroviral therapy in response to revised recommendations issued by the Department of Health and Human Services.

Click here for more slides

Bookstore

Psychiatric Disorders in HIV-Infected Patients

Request your free copy of this popular CME-certified print program (available in the US and Canada only).

 

Click here for the bookstore

Tools

Drug-Drug Interactions in HIV-Infected Patients

Search for interactions between antiretrovirals and with other medications.

 

Click here for more tools

Cases

Managing Adherence in a Patient With Multiple Medical Disorders and an Affective Disorder

 

Mary Alice O’Dowd, MD, guides the participant through a case involving a middle-aged patient with multiple medical disorders who must manage her antiretroviral medications, her other essential medications, and treatment for an affective disorder.
 

Click here for more cases

Expert Commentary

from our Advisory Board & leading experts

Journal Options for November 2008

By:

David M. Margolis, MD

Associate Professor
University of Texas Southwestern Medical School
Chief, Infectious Diseases Section
Dallas Veterans Affairs Medical Center
Dallas, Texas

More Journal Options

Expert Viewpoint for June 2007

By:

David Alain Wohl, MD

Clinical Associate Professor
AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

More Expert Viewpoints

CME Options

CME-certified programs developed independently by CCO’s educational partners. Click here for the full list.

Contemporary Views of Metabolic Complications and Cardiovascular Risk in HIV-Infected Patients